Organon (OGN) EBIAT (2020 - 2025)
Historic EBIAT for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $160.0 million.
- Organon's EBIAT fell 5543.18% to $160.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $501.0 million, marking a year-over-year decrease of 6149.12%. This contributed to the annual value of $864.0 million for FY2024, which is 1554.25% down from last year.
- Latest data reveals that Organon reported EBIAT of $160.0 million as of Q3 2025, which was down 5543.18% from $145.0 million recorded in Q2 2025.
- Organon's EBIAT's 5-year high stood at $546.0 million during Q4 2023, with a 5-year trough of $58.0 million in Q3 2023.
- Its 5-year average for EBIAT is $239.5 million, with a median of $202.0 million in 2021.
- Over the last 5 years, Organon's EBIAT had its largest YoY gain of 51896.55% in 2024, and its largest YoY loss of 8003.66% in 2024.
- Organon's EBIAT (Quarter) stood at $202.0 million in 2021, then crashed by 46.53% to $108.0 million in 2022, then soared by 405.56% to $546.0 million in 2023, then plummeted by 80.04% to $109.0 million in 2024, then surged by 46.79% to $160.0 million in 2025.
- Its EBIAT stands at $160.0 million for Q3 2025, versus $145.0 million for Q2 2025 and $87.0 million for Q1 2025.